Rethinking cancer drug synergy prediction: a call for standardization in machine learning applications
Wong, A. M.; Crawford, L.
Show abstract
Drug resistance poses a significant challenge to cancer treatment, often caused by intratumor heterogeneity. Combination therapies have been shown to be an effective strategy to prevent resistant cancer cells from escaping single-drug treatments. However, discovering new drug combinations through traditional molecular assays can be costly and time-consuming. In silico approaches can overcome this limitation by exploring many candidate combinations at scale. This study systematically evaluates the utility of various machine learning algorithms, input features, and drug synergy prediction tasks. Our findings indicate a pressing need for establishing a standardized framework to measure and develop algorithms capable of predicting synergy.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Tissue-guided LASSO for prediction of clinical drug response using preclinical samples 96%
- A regularized functional regression model enabling transcriptome-wide dosage-dependent association study of cancer drug response 95%
- Impact of between-tissue differences on pan-cancer predictions of drug sensitivity 95%
Similar papers in this journal
- COMIC: Explainable Drug Repurposing via Contrastive Masking for Interpretable Connections 96%
- Quantitative Structure-Mutation-Activity Relationship Tests (QSMART) Model for Protein Kinase Inhibitor Response Prediction 95%
- Drug mechanism enrichment analysis improves prioritization of therapeutics for repurposing 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.